CME and CFTC Engage in Heated Battle Over On-Chain Perpetual Futures

The feud between the CME Group and the U.S. Commodity Futures Trading Commission (CFTC) has intensified, with the CME suing the regulator over its decision to allow blockchain-based perpetual futures products. The CME argues that these products, which enable users to speculate on asset prices with leverage and no expiration date, are harmful to its traditional futures products and that the CFTC's approval process was flawed. The dispute has significant implications for the rapidly growing market, with non-U.S. perpetual futures volume reportedly reaching $60 trillion in 2023. The CFTC's chairman, Mike Selig, has defended the agency's approach, stating that it is committed to undertaking a reasoned analysis of the issues at stake. However, the CME's chairman, Terry Duffy, has expressed concerns that the CFTC's policy may not be properly enforced, particularly with regards to blocking non-U.S. traders from participating in regulated platforms. The lawsuit has sparked a heated debate, with some arguing that the CME is attempting to stifle innovation and competition, while others see the CFTC's approach as a necessary step to promote the development of the U.S. crypto market.